Connect to other sites within the UBM Medica Network
Anticoagulant Use Among Afib Patients Wanes Over Time
Study results presented at the 2015 AHA meeting reinforce, once again, the critical role of persistent patient education on treatment adherence.
Risk of Atrial Fibrillation Increased in HFpEF
Data from a recent study suggest that paroxysmal AF may be underdiagnosed in patients with heart failure and preserved ejection fraction.
Atrial Fibrillation May Increase Risk of Dementia
Younger patients with AF of longer duration were found at higher risk for dementia, a recent study found.
Ablation Therapy for AF: Who, What is it Good For?
Guidelines recommend AF catheter ablation to help avoid use of oral anticoagulation. True or False? Answer this and 2 other queries on ablation.
Persistent AF Improved via LAA Isolation
Results of the BELIEF study presented at ESC 2015 suggest the adjunctive ablation procedure may enhance long-term rhythm control.
ESC '15: Real World Patients, Real World Numbers from GARFIELD-AF
The first results from the largest ongoing international registry of newly diagnosed AF patients were long awaited, and worth the wait.
Stroke Rounds: Muddled Thinking May Signal CV Event Risk
Results of a new study suggest that changes in cognitive function may reflect more global vascular damage and serve as a surrogate marker.
12 Bits On Chocolate and Health
Is eating chocolate good for your patients’ health or bad? Savor these slides for a concise summary of this favorite food’s medicinal pros and cons.
Cardiology Update: 6 New Things From ACP
It’s time to rethink aspirin; there’s optimism about the PCSK9 inhibitors; and new help for people with valvular heart disease. What else is new in cardiology?
3 Myths About New Oral Anticoagulants Debunked for Primary Care Physicians
No monitoring necessary; don't use them before electrical cardioversion; and count them out for periprocedural use during AF ablation. Really?
Atrial Fibrillation: More Than an Electrical Problem
A small study highlights a big point: manage risk factors that affect the atrial fibrillation substrate and ablation therapy success rates improve (ARREST-AF Cohort Study).
By clicking Accept, you agree to become a member of the UBM Medica Community.